COVID-19 Vaccine: The Fight Against SARS-CoV-2 Infection

Authors

  • Saima Syeda , Anju Shrivastava Department of Zoology, University of Delhi, Delhi-110007, India. Author

DOI:

https://doi.org/10.52253/vjta.2021.v02i01.04

Keywords:

SARS-CoV-2, vaccine platforms, COVID-19 vaccine

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the pandemic in the year 2020, leading to disruption of the healthcare system with a great impact on socio-economy worldwide. Owing to this, an accelerated development of safe and efficient vaccines is required to fight against this virus. In this line, various vaccine development platforms have been exploited globally in order to manage the exponentially increasing rate of infection and mortality. Some vaccines in clinical phase trials have entered into emergency use authorization by few countries while others are in a preclinical stage. The present review summarizes the various platforms of vaccine development and also gives an insight into the vaccination programme initiated in India.

Downloads

Download data is not yet available.

Published

29-04-2021

Share it

How to Cite

COVID-19 Vaccine: The Fight Against SARS-CoV-2 Infection. (2021). Vantage: Journal of Thematic Analysis , 2(1), 42-66. https://doi.org/10.52253/vjta.2021.v02i01.04

Similar Articles

11-20 of 40

You may also start an advanced similarity search for this article.